Glucotrack, INC. (GCTK) — 10-Q Filings

10-Q Filings (6)

• Glucotrack's Losses Widen Amid Clinical Progress, Liquidity Concerns — Nov 13, 2025 Risk: high
  Glucotrack, Inc. (GCTK) reported a net loss of $15.76 million for the nine months ended September 30, 2025, an increase from $12.503 million in the same period
• Glucotrack's Losses Widen Amid Clinical Progress, Capital Raise — Aug 14, 2025 Risk: high
  Glucotrack, Inc. (GCTK) reported a net loss of $11.589 million for the six months ended June 30, 2025, a significant increase from the $7.416 million loss in th
• Glucotrack, Inc. Files Q1 2025 10-Q Report — May 14, 2025 Risk: low
  Glucotrack, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as Integrity Applications, Inc., is based in Rut
• Glucotrack, Inc. Files Q3 2024 Report — Nov 14, 2024 Risk: medium
  Glucotrack, Inc. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Integrity Applications, Inc., is based in R
• Glucotrack, Inc. Files Q2 2024 10-Q Report — Aug 13, 2024 Risk: medium
  Glucotrack, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Integrity Applications, Inc., is based in Rutherford, NJ. Th
• GlucoTrack, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  GlucoTrack, Inc. (GCTK) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. GlucoTrack, Inc. filed a 10-Q report for the period ending March 31, 2024.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX